{"entity":{"type":"insider","cik":"0001673892","url":"/insider/0001673892","json_url":"/insider/0001673892.json","name":"OrbiMed Global Healthcare GP LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":2,"first":"2016-05-13","last":"2018-07-24","span_basis":"filed_date"},"name_variants":[{"name":"OrbiMed Global Healthcare GP LLC","source":"filing","n_filings":2,"first_seen":"2016-05-13","last_seen":"2018-07-24"}],"transactions":[{"id":6282985,"accession":"0000899243-18-020515","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-18-020515","line_url":"/filing/0000899243-18-020515","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"CONSTELLATION PHARMACEUTICALS INC","issuer_ticker":"CNST","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Capital GP VI LLC; OrbiMed Global Healthcare GP LLC; ORBIMED ADVISORS LLC","owner_display_name":"OrbiMed Capital GP VI LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":417921.0,"shares_owned_after_display":"417,921","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-07-23","filed_date":"2018-07-24","scope":"insider","n_lines":2},{"id":2103755,"accession":"0001209191-16-119992","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-16-119992","line_url":"/filing/0001209191-16-119992","is_derivative":false,"issuer_cik":"0001055949","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001055949","owner_cik":null,"owner_name":"ISALY SAMUEL D; OrbiMed Capital GP V LLC; OrbiMed Global Healthcare GP LLC; ORBIMED ADVISORS LLC","owner_display_name":"ISALY SAMUEL D","owner_url":null,"role":"Director","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":4500000.0,"total_display":"4,500,000.00","total_whole":"4,500,000","shares_owned_after":2603646.0,"shares_owned_after_display":"2,603,646","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-11","filed_date":"2016-05-13","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001434418","name":"CONSTELLATION PHARMACEUTICALS INC","url":"/issuer/0001434418","role":"Ten percent owner","n_filings":1,"first_seen":"2018-07-24","last_seen":"2018-07-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001652130","name":"Intellia Therapeutics, Inc.","url":"/issuer/0001652130","role":"Director","n_filings":1,"first_seen":"2016-05-13","last_seen":"2016-05-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001673892","retrieved_at":"2026-08-23T21:45:31+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}